文献速递免疫规划慢病防控与筛查

老年人序贯与单剂肺炎球菌疫苗接种对心血管疾病的影响:一项基于人群的队列研究

Effects of sequential vs single pneumococcal vaccination on cardiovascular diseases among older adults: a population-based cohort study.
PubMed 文献 · Int J Epidemiol · 2024-01-01

该研究基于香港2012至2020年回顾性队列,纳入65岁及以上单剂或序贯双剂肺炎球菌疫苗接种者,倾向评分匹配后每组69390人,中位随访1.89年。序贯双剂接种者心血管疾病风险低于单剂接种者(HR 0.75,95%CI 0.71-0.80,P<0.001),中介分析显示该风险降低由全因肺炎减少介导。

要点

  • 序贯双剂肺炎球菌疫苗接种者心血管疾病风险低于单剂接种者,HR 0.75(95%CI 0.71-0.80,P<0.001)。
  • 中介分析显示心血管风险降低由全因肺炎减少介导。
  • 作者认为制定肺炎球菌疫苗接种决策时应考虑额外心血管获益。

核心结论

  • 在老年人中,与单剂PCV13或PPSV23相比,序贯双剂肺炎球菌疫苗接种与较低的心血管疾病风险相关。
  • 作者认为制定肺炎球菌疫苗接种决策时应考虑这种额外的心血管获益。

研究设计与样本

  • 香港2012至2020年回顾性队列研究。
  • 纳入65岁及以上接受单剂或序贯双剂肺炎球菌疫苗接种的成年人,随访至心血管疾病发生、死亡或研究结束。
  • 按倾向评分将每名单剂接种者与一名序贯接种者匹配,匹配后每组69390人。
  • 采用Cox回归估计心血管疾病风险的风险比,并应用结构方程模型检验序贯双剂接种对心血管疾病的影响是否通过减少肺炎介导。

主要发现

  • 匹配后每组69390人,中位(四分位距)随访时间为1.89(1.55)年。
  • 与单剂疫苗接种者相比,序贯双剂疫苗接种者的心血管疾病风险更低(HR 0.75,95%CI 0.71-0.80,P<0.001)。
  • 事后中介分析显示有力证据表明心血管疾病风险降低由全因肺炎减少介导。

临床怎么用

  • 作者认为制定肺炎球菌疫苗接种决策时应考虑序贯双剂接种带来的额外心血管获益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recommendations around the use of 23-valent pneumococcal polysaccharide vaccine (PPSV23) and 13-valent pneumococcal conjugate vaccine (PCV13) seldom focus on potential benefits of vaccine on comorbidities. We aimed to investigate whether sequential vaccination with PCV13 and PPSV23 among older adults would provide protection against cardiovascular diseases (CVD) compared with using a single pneumococcal vaccine. METHODS: We conducted a Hong Kong-wide retrospective cohort study between 2012 and 2020. Adults aged ≥65 years were identified as receiving either a single or sequential dual vaccination and followed up until the earliest CVD occurrence, death or study end. To minimize confounding, we matched each person receiving a single vaccination to a person receiving sequential vaccination according to their propensity scores. We estimated the hazard ratio (HR) of CVD risk using Cox regression and applied structural equation modelling to test whether the effect of sequential dual vaccination on CVD was mediated via the reduction in pneumonia. RESULTS: After matching, 69 390 people remained in each group and the median (interquartile range) follow-up time was 1.89 (1.55) years. Compared with those receiving a single vaccine, those receiving sequential dual vaccination had a lower risk of CVD [HR (95% CI): 0.75 (0.71, 0.80), P < 0.001]. Post-hoc mediation analysis showed strong evidence that the decreased CVD risk was mediated by the reduction in all-cause pneumonia. CONCLUSIONS: Sequential dual pneumococcal vaccination was associated with lower risk of CVD compared with single-dose PCV13 or PPSV23 in older adults. Such additional CVD benefits should be considered when making decisions about pneumococcal vaccination.

来源:Int J Epidemiol,查看原文。版权归原作者所有。

引用

  1. Tong X, Gao L, Wong ICK, et al. Effects of sequential vs single pneumococcal vaccination on cardiovascular diseases among older adults: a population-based cohort study. Int J Epidemiol. 2024. PMID: 38332579. doi:10.1093/ije/dyae005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。